Published in Hepatology on June 01, 2009
Occult HBV infection. Semin Immunopathol (2012) 1.37
Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections. Transfusion (2013) 1.12
Genotyping and molecular characterization of hepatitis B virus from human immunodeficiency virus-infected individuals in southern Africa. PLoS One (2012) 0.95
Occult hepatitis B virus infection. World J Hepatol (2014) 0.90
Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan. J Clin Microbiol (2010) 0.89
Characterization of occult hepatitis B virus infection from blood donors in China. J Clin Microbiol (2011) 0.89
The clinical significance of occult HBV infection. Ann Gastroenterol (2014) 0.83
Sequence variations of full-length hepatitis B virus genomes in Chinese patients with HBsAg-negative hepatitis B infection. PLoS One (2014) 0.76
Mutations associated with occult hepatitis B in HIV-positive South Africans. J Med Virol (2014) 0.76
Genetic linkage of hepatitis B virus in peripheral blood leukocytes provides evidence for contamination. J Virol (2010) 0.75
Screening and diagnosis of HBV in low-income and middle-income countries. Nat Rev Gastroenterol Hepatol (2016) 0.75
Occult HBV among Anti-HBc Alone: Mutation Analysis of an HBV Surface Gene and Pre-S Gene. Yonsei Med J (2017) 0.75
Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion (2005) 3.08
Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7. PLoS Pathog (2012) 1.88
Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med (2011) 1.69
The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood (2002) 1.66
Cancer in the Republic of the Marshall Islands. Pac Health Dialog (2004) 1.60
Infectivity of blood products from donors with occult hepatitis B virus infection. Transfusion (2013) 1.43
Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion (2009) 1.41
Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood (2005) 1.39
Changing epidemiology of human parvovirus 4 infection in sub-Saharan Africa. Emerg Infect Dis (2010) 1.36
Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol (2008) 1.30
Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms. Transfusion (2010) 1.29
Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol (2007) 1.28
Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol (2008) 1.25
Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection. Hepatology (2010) 1.23
Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections. Transfusion (2013) 1.12
Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges. Transfus Med Rev (2011) 1.11
Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk. Transfusion (2011) 1.10
Diagnostic algorithm for HBV safe transfusion. Blood Transfus (2009) 1.08
A pool of repeat blood donors can be generated with little expense to the blood center in sub-Saharan Africa. Transfusion (2008) 1.04
HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells. AIDS (2009) 1.03
Simultaneous visual detection of multiple viral amplicons by dipstick assay. J Clin Microbiol (2005) 1.02
Molecular characterization of occult hepatitis B virus in genotype E-infected subjects. J Gen Virol (2008) 1.01
Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain. Transfusion (2009) 1.00
Molecular epidemiology of HIV in Ghana: dominance of CRF02_AG. J Med Virol (2004) 1.00
Challenges in hepatitis B detection among blood donors. Curr Opin Hematol (2011) 1.00
Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects. Vox Sang (2006) 1.00
Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors. Transfusion (2013) 0.99
Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence. Gut (2012) 0.99
A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assays. Transfusion (2010) 0.97
Multiplex real-time PCR for the detection and quantification of latent and persistent viral genomes in cellular or plasma blood fractions. J Virol Methods (2008) 0.97
Comparison of human immunodeficiency virus assays in window phase and elite controller samples: viral load distribution and implications for transmission risk. Transfusion (2013) 0.95
Characteristics of Marshallese with Type 2 Diabetes on Oahu: A Pilot Study to Implement a Community-Based Diabetic Health Improvement Project. Calif J Health Promot (2005) 0.95
Pilot studies for development of an HIV subtype panel for surveillance of global diversity. AIDS Res Hum Retroviruses (2012) 0.95
A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period. Transfusion (2008) 0.94
High seroprevalence of enterovirus infections in apes and old world monkeys. Emerg Infect Dis (2012) 0.90
Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan. J Clin Microbiol (2010) 0.89
Characterization of occult hepatitis B virus infection from blood donors in China. J Clin Microbiol (2011) 0.89
Hepatitis B virus in transfusion medicine: still a problem? Biologicals (2012) 0.88
Deletions and recombinations in the core region of hepatitis B virus genotype E strains from asymptomatic blood donors in Guinea, west Africa. J Gen Virol (2009) 0.87
Comparison of seven hepatitis B virus (HBV) nucleic acid testing assays in selected samples with discrepant HBV marker results from United States blood donors. Transfusion (2014) 0.86
Higher viral load may explain the dominance of CRF02_AG in the molecular epidemiology of HIV in Ghana. AIDS (2004) 0.86
Seroconverting blood donors as a resource for characterising and optimising recent infection testing algorithms for incidence estimation. PLoS One (2011) 0.83
Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors. Transfusion (2005) 0.82
A retrospective study of 75 cases of splenic abscess. Indian J Surg (2011) 0.82
Role of regulatory agencies. Biologicals (2009) 0.81
No influence of human herpesvirus 8 infection on the progression of HIV-1 infection in initially asymptomatic patients. AIDS (2003) 0.81
Truncated forms of human and simian immunodeficiency virus in infected individuals and rhesus macaques are unique or rare quasispecies. Virology (2003) 0.81
GB virus C and HIV-1 RNA load in single virus and co-infected West African individuals. AIDS (2006) 0.80
Reverse vertical transmission of hepatitis B virus (HBV) infection from a transfusion-infected newborn to her mother. J Hepatol (2011) 0.80
Risk assessment and cost-effectiveness/utility analysis. Biologicals (2009) 0.80
Human herpesvirus 8 transfusion transmission in Ghana, an endemic region of West Africa. Transfusion (2012) 0.78
Specific amino acid substitutions in the S protein prevent its excretion in vitro and may contribute to occult hepatitis B virus infection. J Virol (2013) 0.77
Evidence of serological cross-reactivity between genotype 1 and genotype 3 erythrovirus infections. J Virol (2005) 0.77
Resident-driven group medical visits for diabetes mellitus in an ethnically diverse clinic population. Hawaii Med J (2010) 0.76
A mathematical approach to estimate the efficacy of individual-donation and minipool nucleic acid amplification test options in preventing transmission risk by window period and occult hepatitis B virus infections. Transfusion (2014) 0.76
Efficacy of POSSUM score in predicting the outcome in patients undergoing emergency laparotomy. Pol Przegl Chir (2014) 0.76
Impact of hepatitis B virus genotypes and surface antigen variants on the performance of HBV real time PCR quantification. J Virol Methods (2009) 0.76
Predonation testing of potential blood donors in resource-restricted settings. Transfusion (2005) 0.75
Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in eight provinces of South Africa in November 2021. Res Sq (2022) 0.75
Hepatitis C virus infection in long-term nonprogressor HIV-1-infected subjects. J Acquir Immune Defic Syndr (2002) 0.75
A clinical audit of the utilisation of red cell products in elective total hip replacement surgery. S Afr Med J (2016) 0.75
Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa. Emerg Infect Dis (2017) 0.75
Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization. PLoS Pathog (2017) 0.75
Design of a dual-hormone model predictive control for artificial pancreas with exercise model. Conf Proc IEEE Eng Med Biol Soc (2016) 0.75